Biomarkers of METAP2 inhibitors and applications thereof Grant US-11612577-B2 United States of America 28 Mar 2023
MetAP2 inhibitors and methods of treating obesity Grant US-11304944-B2 United States of America 19 Apr 2022
Treatment for tumors driven by metabolic dysfunction Grant US-11273142-B2 United States of America 15 Mar 2022
Polymer-conjugated METAP2 inhibitors, and therapeutic methods of use thereof Grant US-10722532-B2 United States of America 28 Jul 2020
Treatment for tumors driven by metabolic dysfunction Grant US-10646463-B2 United States of America 12 May 2020
METAP2 inhibitors and methods of treating obesity Grant US-10588904-B2 United States of America 17 Mar 2020
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof Grant US-10159692-B2 United States of America 25 Dec 2018
PHARMACEUTICAL COMPOSITIONS OF METAP-2 INHIBITORS Application WO-2018148638-A1 World Intellectual Property Organisation (WIPO) 16 Aug 2018
METAP2 inhibitors and methods of treating obesity Grant US-10010544-B2 United States of America 03 Jul 2018
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof Grant US-9895449-B2 United States of America 20 Feb 2018
TREATMENT FOR TUMORS DRIVEN BY METABOLIC DYSFUNCTION Application WO-2017123603-A1 World Intellectual Property Organisation (WIPO) 20 Jul 2017
Tricyclic sulfone compounds and methods of making and using same Grant US-9440943-B2 United States of America 13 Sep 2016
TRICYCLIC SULFONE COMPOUNDS AND METHODS OF MAKING AND USING SAME Application US-20150119456-A1 United States of America 30 Apr 2015